triglyceride/悪性腫瘍

FIELD OF INVENTION The present invention relates to the treatment of cancers. More particularly, the invention relate to methods, compounds, and compositions for the treatment of pancreatic cancer in a human patient. BACKGROUND OF INVENTION Cancer refers to more than one hundred clinically distinct

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a diagnostic method and apparatus for the detection of cancer in a living patient. 2. Prior Art Attempts utilizing the technique of nuclear magnetic resonance (NMR) to aid in arriving at a clinical diagnosis of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an apparatus and diagnostic method for detecting cancer in a living patient. 2. Prior Art Approaches utilizing the technique of nuclear magnetic resonance (NMR) to aid in arriving at a clinical diagnosis of cancer

FIELD OF INVENTION The present invention relates to structured triglycerides, to emulsions comprising same suitable for parenteral nutrition, and use thereof. In particular, the invention relates to structured triglycerides comprising at least one medium chain C.sub.6-C.sub.12 fatty acid and at

CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. national stage application of International Application No. PCT/EP2015/051657, filed on Jan. 28, 2015, which claims priority to European Application No. 14152785.3, filed on Jan. 28, 2014. The contents of these previously filed

CROSS-REFERENCE TO RELATED APPLICATIONS This application is filed under the provisions of 35 U.S.C. .sctn. 371 and claims the priority of International Patent Application No. PCT/EP2015/074321, filed on 21 Oct. 2015 entitled "METHOD FOR THE SYNTHESIS OF HYDROXY-TRIGLYCERIDES AND USES THEREOF FOR THE

BACKGROUND OF THE INVENTION The present invention relates to therapeutic compositions of carotenoids encapsulated in liposomes or other lipid carrier particles. It has been known for more than 50 years that retinoids, the family of molecules comprising both the natural and synthetic analogues of

BACKGROUND OF THE INVENTION The present invention relates to therapeutic compositions of carotenoids encapsulated in liposomes or other lipid carrier particles. It has been known for more than 50 years that retinoids, the family of molecules comprising both the natural and synthetic analogues of

I. FIELD OF THE INVENTION This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer

I. FIELD OF THE INVENTION This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer

I. FIELD OF THE INVENTION This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer

CROSS REFERENCE TO RELATED PATENT APPLICATION The present application claims a priority of the Chinese patent application CN201410342417.6 with filing date Jul. 18, 2014, which application is incorporated herein by reference. FIELD OF THE INVENTION The present invention relates to the pharmaceutical

CROSS REFERENCE TO RELATED PATENT APPLICATION The present application is the US national stage of PCT/CN2015/084297 filed on Jul. 17, 2015, which claims the priority of the Chinese patent application No. 201410343083.4 filed on Jul. 18, 2014, which applications are incorporated herein by

This invention relates to pharmaceutically-acceptable compositions, and more particularly to injectable compositions comprising ether phospholipid or carbamoyl salts and triglyceride-water emulsions as well as the use thereof. Certain ether phospholipid and carbamoyl salts are useful as platelet

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel lipid emulsion having the activity of potentiating the anti-cancer activity of an anti-cancer agent, a method of potentiating the activities of anti-cancer agents by using it with the lipid emulsion, and to a